Back to results
US 2020/0392190 A1Published application
Flagellin-based agents and uses including effective vaccination
AssigneeGenome Protection, Inc.
InventorsAndrei V. GUDKOV, Vadim METT, Vadim KRIVOKRYSENKO
Life of this patent
Estimating the term…
Abstract
The present invention relates to, in part, compositions comprising improved flagellin derived constructs and methods of using for vaccination, including adjuvants comprising flagellin-based agents.
Claims16
-33. (canceled)
A method of vaccinating a subject against a disorder, comprising administering an effective amount of a vaccine comprising:
- (a) an adjuvant comprising:
- a flagellin-based agent comprising an amino acid sequence having at least 95% identity with one of SEQ ID NO:
- 35, 71, and 150, and
- an aluminum gel or salt,
- wherein the ratio (w/w) of flagellin-based agent to aluminum gel or salt is about 1:500 or less and
- (b) an antigen which stimulates protective immunity against the disorder,
- wherein the antigen is a constituent of an infectious agent selected from a live and attenuated, killed, inactivated, and toxoid infectious agent;
- and wherein the disorder is selected from infectious diseases, cancers, and allergies.
5 more elements
Dependencies are inferred from the claim text.